Cerulea Clinical Trials

Science and Research


A Study to Genetically Define Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration. TELESCOPE is a community-based genetic screening study designed to identify people with Geographic Atrophy (GA), secondary to Age-related Macular Degeneration (AMD) who have a certain genetic profile.


In the study, a person’s genetic profile is determined through a process called “genotyping” using saliva samples provided by the potential participants.

Genotyping is a process whereby a person’s DNA is evaluated using biological tests to determine differences in their genetic makeup, when compared to other individuals. A certain genetic makeup might indicate a predisposition to a disease like dry AMD.

The results of the saliva test may qualify participants for enrolment into one of Gyroscope’s ongoing trials evaluating a gene therapy for GA.


  • Principal Investigator
Associate Professor Zhichao Wu